Drug Standards
- (2)
- (4)
- (1)
- (3)
- (3)
- (665)
- (3)
- (27)
- (1)
- (6)
- (27)
- (61)
- (24)
- (1)
- (2)
- (35)
- (367)
- (45)
- (1)
- (2)
- (1)
- (5)
- (5)
- (4)
- (2)
- (7)
- (1)
- (5)
- (4)
- (3)
- (3)
- (1)
- (3)
- (2)
- (2)
- (1)
- (2)
- (3)
- (4)
- (2)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (5)
- (1)
- (2)
- (4)
- (1)
- (1)
- (3)
- (5)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (3)
- (1)
- (1)
- (3)
- (4)
- (2)
- (2)
- (1)
- (4)
- (4)
- (5)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (4)
- (3)
- (1)
- (4)
- (1)
- (2)
- (1)
- (5)
- (2)
- (2)
- (1)
- (5)
- (7)
- (3)
- (1)
- (1)
- (1)
- (4)
- (1)
- (3)
- (1)
- (4)
- (1)
- (8)
- (2)
- (1)
- (5)
- (13)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (4)
- (1)
- (5)
- (1)
- (1)
- (2)
- (1)
- (6)
- (2)
- (1)
- (2)
- (2)
- (1)
- (3)
- (1)
- (2)
- (2)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1)
- (2)
- (4)
- (3)
- (1)
- (1)
- (5)
- (3)
- (2)
- (5)
- (1)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (4)
- (4)
- (1)
- (2)
- (2)
- (1)
- (2)
- (4)
- (5)
- (2)
- (1)
- (3)
- (2)
- (2)
- (11)
- (1)
- (2)
- (2)
- (2)
- (5)
- (5)
- (4)
- (2)
- (4)
- (2)
- (1)
- (2)
- (5)
- (2)
- (2)
- (1)
- (2)
- (3)
- (2)
- (2)
- (5)
- (3)
- (2)
- (2)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (2)
- (3)
- (2)
- (2)
- (3)
- (2)
- (1)
- (1)
- (5)
- (1)
- (2)
- (5)
- (5)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (7)
- (2)
- (2)
- (1)
- (3)
- (1)
- (3)
- (2)
- (5)
- (2)
- (2)
- (2)
- (2)
- (5)
- (2)
- (1)
- (6)
- (3)
- (2)
- (1)
- (5)
- (5)
- (2)
- (2)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (5)
- (1)
- (2)
- (4)
- (1)
- (3)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (5)
- (2)
- (2)
- (1)
- (1)
- (2)
- (8)
- (4)
- (14)
- (7)
- (8)
- (1)
- (3)
- (1)
- (6)
- (1)
- (1)
- (5)
- (2)
- (1)
- (1)
- (2)
- (20)
- (4)
- (5)
- (1)
- (3)
- (2)
- (1)
- (7)
- (8)
- (7)
- (2)
- (1)
- (2)
- (1)
- (3)
- (5)
- (5)
- (1)
- (3)
- (1)
- (3)
- (6)
- (3)
- (3)
- (1)
- (2)
- (26)
- (54)
- (5)
- (11)
- (4)
- (6)
- (6)
- (16)
- (1)
- (129)
- (3)
- (1)
- (2)
- (5)
- (4)
- (14)
- (38)
- (3)
- (13)
- (12)
- (7)
- (1)
- (6)
- (6)
- (6)
- (1)
- (1)
- (1)
- (1)
- (1)
- (12)
- (38)
- (5)
- (1)
- (2)
- (1)
- (1)
- (12)
- (2)
- (15)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (6)
- (15)
- (2)
- (1)
- (19)
- (3)
- (18)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (29)
- (3)
- (2)
- (1)
- (2)
- (1)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (44)
- (2)
- (27)
- (1)
- (73)
- (6)
- (73)
Filtered Search Results
Griseofulvin Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Ezetimibe Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
Montelukast sodium, 98%
CAS: 151767-02-1 Molecular Formula: C35H35ClNNaO3S Molecular Weight (g/mol): 608.17 MDL Number: MFCD00931431 InChI Key: LBFBRXGCXUHRJY-HKHDRNBDSA-M PubChem CID: 23663996 ChEBI: CHEBI:6993 IUPAC Name: sodium;2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate SMILES: [Na+].CC(C)(O)C1=CC=CC=C1CC[C@@H](SCC1(CC([O-])=O)CC1)C1=CC=CC(\C=C\C2=CC=C3C=CC(Cl)=CC3=N2)=C1
| PubChem CID | 23663996 |
|---|---|
| CAS | 151767-02-1 |
| Molecular Weight (g/mol) | 608.17 |
| ChEBI | CHEBI:6993 |
| MDL Number | MFCD00931431 |
| SMILES | [Na+].CC(C)(O)C1=CC=CC=C1CC[C@@H](SCC1(CC([O-])=O)CC1)C1=CC=CC(\C=C\C2=CC=C3C=CC(Cl)=CC3=N2)=C1 |
| IUPAC Name | sodium;2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate |
| InChI Key | LBFBRXGCXUHRJY-HKHDRNBDSA-M |
| Molecular Formula | C35H35ClNNaO3S |
Lisinopril Dihydrate 98.0+%, TCI America™
Molecular Formula: C21H33N3O6 Molecular Weight (g/mol): 423.51 MDL Number: MFCD01698825 InChI Key: BAVDEDVBIHTHJQ-UVJOBNTFSA-N Synonym: 1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline PubChem CID: 22887897 IUPAC Name: (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid;hydrate SMILES: C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O.O
| PubChem CID | 22887897 |
|---|---|
| Molecular Weight (g/mol) | 423.51 |
| MDL Number | MFCD01698825 |
| SMILES | C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O.O |
| Synonym | 1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline |
| IUPAC Name | (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid;hydrate |
| InChI Key | BAVDEDVBIHTHJQ-UVJOBNTFSA-N |
| Molecular Formula | C21H33N3O6 |
Abiraterone Acetate 98.0+%, TCI America™
CAS: 154229-18-2 Molecular Formula: C26H33NO2 Molecular Weight (g/mol): 391.555 MDL Number: MFCD00934213 InChI Key: UVIQSJCZCSLXRZ-UBUQANBQSA-N Synonym: 3beta-17-(3-Pyridyl)androsta-5,16-dien-3-ol Acetate PubChem CID: 9821849 ChEBI: CHEBI:68639 IUPAC Name: [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate SMILES: CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C
| PubChem CID | 9821849 |
|---|---|
| CAS | 154229-18-2 |
| Molecular Weight (g/mol) | 391.555 |
| ChEBI | CHEBI:68639 |
| MDL Number | MFCD00934213 |
| SMILES | CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C |
| Synonym | 3beta-17-(3-Pyridyl)androsta-5,16-dien-3-ol Acetate |
| IUPAC Name | [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate |
| InChI Key | UVIQSJCZCSLXRZ-UBUQANBQSA-N |
| Molecular Formula | C26H33NO2 |
Nitazoxanide 98.0+%, TCI America™
CAS: 55981-09-4 Molecular Formula: C12H9N3O5S Molecular Weight (g/mol): 307.28 MDL Number: MFCD00416599 InChI Key: YQNQNVDNTFHQSW-UHFFFAOYSA-N Synonym: 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide, NTZ PubChem CID: 41684 IUPAC Name: [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate SMILES: CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]
| PubChem CID | 41684 |
|---|---|
| CAS | 55981-09-4 |
| Molecular Weight (g/mol) | 307.28 |
| MDL Number | MFCD00416599 |
| SMILES | CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-] |
| Synonym | 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide, NTZ |
| IUPAC Name | [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate |
| InChI Key | YQNQNVDNTFHQSW-UHFFFAOYSA-N |
| Molecular Formula | C12H9N3O5S |
Pemetrexed Hydrate 98.0+%, TCI America™
CAS: 137281-23-3 Molecular Formula: C20H21N5O6 Molecular Weight (g/mol): 427.417 MDL Number: MFCD19105065 InChI Key: WBXPDJSOTKVWSJ-ZDUSSCGKSA-N Synonym: N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid PubChem CID: 446556 ChEBI: CHEBI:63616 IUPAC Name: (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid SMILES: C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
| PubChem CID | 446556 |
|---|---|
| CAS | 137281-23-3 |
| Molecular Weight (g/mol) | 427.417 |
| ChEBI | CHEBI:63616 |
| MDL Number | MFCD19105065 |
| SMILES | C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O |
| Synonym | N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid |
| IUPAC Name | (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid |
| InChI Key | WBXPDJSOTKVWSJ-ZDUSSCGKSA-N |
| Molecular Formula | C20H21N5O6 |
Penciclovir 98.0+%, TCI America™
CAS: 39809-25-1 Molecular Formula: C10H15N5O3 Molecular Weight (g/mol): 253.262 MDL Number: MFCD15142866 InChI Key: JNTOCHDNEULJHD-UHFFFAOYSA-N Synonym: BRL 39123, 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-1H-purin-6-one, 9-[4-Hydroxy-3-(hydroxymethyl)butyl]guanine PubChem CID: 4725 ChEBI: CHEBI:7956 IUPAC Name: 2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3H-purin-6-one SMILES: C1=NC2=C(N1CCC(CO)CO)NC(=NC2=O)N
| PubChem CID | 4725 |
|---|---|
| CAS | 39809-25-1 |
| Molecular Weight (g/mol) | 253.262 |
| ChEBI | CHEBI:7956 |
| MDL Number | MFCD15142866 |
| SMILES | C1=NC2=C(N1CCC(CO)CO)NC(=NC2=O)N |
| Synonym | BRL 39123, 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-1H-purin-6-one, 9-[4-Hydroxy-3-(hydroxymethyl)butyl]guanine |
| IUPAC Name | 2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3H-purin-6-one |
| InChI Key | JNTOCHDNEULJHD-UHFFFAOYSA-N |
| Molecular Formula | C10H15N5O3 |
Pioglitazone Hydrochloride 98.0+%, TCI America™
CAS: 112529-15-4 Molecular Formula: C19H21ClN2O3S Molecular Weight (g/mol): 392.898 MDL Number: MFCD04975446 InChI Key: GHUUBYQTCDQWRA-UHFFFAOYSA-N Synonym: 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione Hydrochloride PubChem CID: 60560 IUPAC Name: 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride SMILES: CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl
| PubChem CID | 60560 |
|---|---|
| CAS | 112529-15-4 |
| Molecular Weight (g/mol) | 392.898 |
| MDL Number | MFCD04975446 |
| SMILES | CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl |
| Synonym | 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione Hydrochloride |
| IUPAC Name | 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride |
| InChI Key | GHUUBYQTCDQWRA-UHFFFAOYSA-N |
| Molecular Formula | C19H21ClN2O3S |
Repaglinide 98.0+%, TCI America™
CAS: 135062-02-1 Molecular Formula: C27H36N2O4 Molecular Weight (g/mol): 452.60 MDL Number: MFCD00906179 InChI Key: FAEKWTJYAYMJKF-QHCPKHFHSA-N Synonym: (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic Acid PubChem CID: 65981 ChEBI: CHEBI:8805 IUPAC Name: 2-ethoxy-4-({[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]carbamoyl}methyl)benzoic acid SMILES: CCOC1=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(O)=O
| PubChem CID | 65981 |
|---|---|
| CAS | 135062-02-1 |
| Molecular Weight (g/mol) | 452.60 |
| ChEBI | CHEBI:8805 |
| MDL Number | MFCD00906179 |
| SMILES | CCOC1=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(O)=O |
| Synonym | (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic Acid |
| IUPAC Name | 2-ethoxy-4-({[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]carbamoyl}methyl)benzoic acid |
| InChI Key | FAEKWTJYAYMJKF-QHCPKHFHSA-N |
| Molecular Formula | C27H36N2O4 |